Forty-one-year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: Cerebellar atrophy, multiphasic relapses, and response to IVIG
Identifieur interne : 002585 ( PascalFrancis/Corpus ); précédent : 002584; suivant : 002586Forty-one-year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: Cerebellar atrophy, multiphasic relapses, and response to IVIG
Auteurs : Michael R. Pranzatelli ; Elizabeth D. Tate ; Marcel Kinshourne ; Verne S. Jr Caviness ; Bibhuti MishraSource :
- Movement disorders [ 0885-3185 ] ; 2002.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
We report on an adult with opsoclonus-myoclonus-ataxia syndrome experiencing widely spaced neurological relapses, who was followed for 41 years. His responses to treatment are described.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
|
---|
Format Inist (serveur)
NO : | PASCAL 03-0038727 INIST |
---|---|
ET : | Forty-one-year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: Cerebellar atrophy, multiphasic relapses, and response to IVIG |
AU : | PRANZATELLI (Michael R.); TATE (Elizabeth D.); KINSHOURNE (Marcel); CAVINESS (Verne S. JR); MISHRA (Bibhuti) |
AF : | The National Pediatric Myoclonus Center, Departments of Neurology and Pediatrics, Southern Illinois University School of Medicine/Springfield, Illinois/Etats-Unis (1 aut., 2 aut.); New School University and Tufts University/Winchester, Massachusetts/Etats-Unis (3 aut.); Massachusetts General Hospital/Boston, Massachusetts/Etats-Unis (4 aut.); Temple University/Philadelphia, Pennsylvania/Etats-Unis (5 aut.) |
DT : | Publication en série; Niveau analytique |
SO : | Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2002; Vol. 17; No. 6; Pp. 1387-1390; Bibl. 20 ref. |
LA : | Anglais |
EA : | We report on an adult with opsoclonus-myoclonus-ataxia syndrome experiencing widely spaced neurological relapses, who was followed for 41 years. His responses to treatment are described. |
CC : | 002B17A01 |
FD : | Ataxie; Cervelet; Opsoclonie; Myoclonie; Immunoglobuline; Voie intraveineuse; Etude cas; Evolution; Récidive; Adulte; Chimiothérapie |
FG : | Homme; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Cervelet pathologie; Trouble neurologique; Oeil pathologie; Oculomotricité syndrome; Mouvement involontaire; Voie administration |
ED : | Ataxia; Cerebellum; Opsoclonus; Myoclonus; Immunoglobulins; Intravenous administration; Case study; Evolution; Relapse; Adult; Chemotherapy |
EG : | Human; Nervous system diseases; Central nervous system disease; Cerebral disorder; Cerebellar disease; Neurological disorder; Eye disease; Oculomotor syndrome; Involuntary movement; Route of administration |
SD : | Ataxia; Cerebelo; Opsoclonación; Mioclonia; Inmunoglobulina; Vía intravenosa; Estudio caso; Evolución; Recaida; Adulto; Quimioterapia |
LO : | INIST-20953.354000105559450430 |
ID : | 03-0038727 |
Links to Exploration step
Pascal:03-0038727Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Forty-one-year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: Cerebellar atrophy, multiphasic relapses, and response to IVIG</title>
<author><name sortKey="Pranzatelli, Michael R" sort="Pranzatelli, Michael R" uniqKey="Pranzatelli M" first="Michael R." last="Pranzatelli">Michael R. Pranzatelli</name>
<affiliation><inist:fA14 i1="01"><s1>The National Pediatric Myoclonus Center, Departments of Neurology and Pediatrics, Southern Illinois University School of Medicine</s1>
<s2>Springfield, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Tate, Elizabeth D" sort="Tate, Elizabeth D" uniqKey="Tate E" first="Elizabeth D." last="Tate">Elizabeth D. Tate</name>
<affiliation><inist:fA14 i1="01"><s1>The National Pediatric Myoclonus Center, Departments of Neurology and Pediatrics, Southern Illinois University School of Medicine</s1>
<s2>Springfield, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kinshourne, Marcel" sort="Kinshourne, Marcel" uniqKey="Kinshourne M" first="Marcel" last="Kinshourne">Marcel Kinshourne</name>
<affiliation><inist:fA14 i1="02"><s1>New School University and Tufts University</s1>
<s2>Winchester, Massachusetts</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Caviness, Verne S Jr" sort="Caviness, Verne S Jr" uniqKey="Caviness V" first="Verne S. Jr" last="Caviness">Verne S. Jr Caviness</name>
<affiliation><inist:fA14 i1="03"><s1>Massachusetts General Hospital</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mishra, Bibhuti" sort="Mishra, Bibhuti" uniqKey="Mishra B" first="Bibhuti" last="Mishra">Bibhuti Mishra</name>
<affiliation><inist:fA14 i1="04"><s1>Temple University</s1>
<s2>Philadelphia, Pennsylvania</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">03-0038727</idno>
<date when="2002">2002</date>
<idno type="stanalyst">PASCAL 03-0038727 INIST</idno>
<idno type="RBID">Pascal:03-0038727</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002585</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Forty-one-year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: Cerebellar atrophy, multiphasic relapses, and response to IVIG</title>
<author><name sortKey="Pranzatelli, Michael R" sort="Pranzatelli, Michael R" uniqKey="Pranzatelli M" first="Michael R." last="Pranzatelli">Michael R. Pranzatelli</name>
<affiliation><inist:fA14 i1="01"><s1>The National Pediatric Myoclonus Center, Departments of Neurology and Pediatrics, Southern Illinois University School of Medicine</s1>
<s2>Springfield, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Tate, Elizabeth D" sort="Tate, Elizabeth D" uniqKey="Tate E" first="Elizabeth D." last="Tate">Elizabeth D. Tate</name>
<affiliation><inist:fA14 i1="01"><s1>The National Pediatric Myoclonus Center, Departments of Neurology and Pediatrics, Southern Illinois University School of Medicine</s1>
<s2>Springfield, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Kinshourne, Marcel" sort="Kinshourne, Marcel" uniqKey="Kinshourne M" first="Marcel" last="Kinshourne">Marcel Kinshourne</name>
<affiliation><inist:fA14 i1="02"><s1>New School University and Tufts University</s1>
<s2>Winchester, Massachusetts</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Caviness, Verne S Jr" sort="Caviness, Verne S Jr" uniqKey="Caviness V" first="Verne S. Jr" last="Caviness">Verne S. Jr Caviness</name>
<affiliation><inist:fA14 i1="03"><s1>Massachusetts General Hospital</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Mishra, Bibhuti" sort="Mishra, Bibhuti" uniqKey="Mishra B" first="Bibhuti" last="Mishra">Bibhuti Mishra</name>
<affiliation><inist:fA14 i1="04"><s1>Temple University</s1>
<s2>Philadelphia, Pennsylvania</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2002">2002</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Ataxia</term>
<term>Case study</term>
<term>Cerebellum</term>
<term>Chemotherapy</term>
<term>Evolution</term>
<term>Immunoglobulins</term>
<term>Intravenous administration</term>
<term>Myoclonus</term>
<term>Opsoclonus</term>
<term>Relapse</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Ataxie</term>
<term>Cervelet</term>
<term>Opsoclonie</term>
<term>Myoclonie</term>
<term>Immunoglobuline</term>
<term>Voie intraveineuse</term>
<term>Etude cas</term>
<term>Evolution</term>
<term>Récidive</term>
<term>Adulte</term>
<term>Chimiothérapie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We report on an adult with opsoclonus-myoclonus-ataxia syndrome experiencing widely spaced neurological relapses, who was followed for 41 years. His responses to treatment are described.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>17</s2>
</fA05>
<fA06><s2>6</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Forty-one-year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: Cerebellar atrophy, multiphasic relapses, and response to IVIG</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>PRANZATELLI (Michael R.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>TATE (Elizabeth D.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>KINSHOURNE (Marcel)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>CAVINESS (Verne S. JR)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>MISHRA (Bibhuti)</s1>
</fA11>
<fA14 i1="01"><s1>The National Pediatric Myoclonus Center, Departments of Neurology and Pediatrics, Southern Illinois University School of Medicine</s1>
<s2>Springfield, Illinois</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>New School University and Tufts University</s1>
<s2>Winchester, Massachusetts</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Massachusetts General Hospital</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Temple University</s1>
<s2>Philadelphia, Pennsylvania</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA20><s1>1387-1390</s1>
</fA20>
<fA21><s1>2002</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000105559450430</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2003 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>20 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>03-0038727</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>We report on an adult with opsoclonus-myoclonus-ataxia syndrome experiencing widely spaced neurological relapses, who was followed for 41 years. His responses to treatment are described.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17A01</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Ataxie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Ataxia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Ataxia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Cervelet</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Cerebellum</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Cerebelo</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Opsoclonie</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Opsoclonus</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Opsoclonación</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Myoclonie</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Myoclonus</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Mioclonia</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Immunoglobuline</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Immunoglobulins</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Inmunoglobulina</s0>
<s5>10</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Voie intraveineuse</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Intravenous administration</s0>
<s5>13</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Vía intravenosa</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Etude cas</s0>
<s5>16</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Case study</s0>
<s5>16</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Estudio caso</s0>
<s5>16</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Evolution</s0>
<s5>17</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Evolution</s0>
<s5>17</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Evolución</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Récidive</s0>
<s5>18</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Relapse</s0>
<s5>18</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Recaida</s0>
<s5>18</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Adulte</s0>
<s5>20</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Adult</s0>
<s5>20</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Adulto</s0>
<s5>20</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Chimiothérapie</s0>
<s5>23</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Chemotherapy</s0>
<s5>23</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Quimioterapia</s0>
<s5>23</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Homme</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Human</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Hombre</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Cervelet pathologie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Cerebellar disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Cerebelar enfermedad</s0>
<s5>40</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Trouble neurologique</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Neurological disorder</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Trastorno neurológico</s0>
<s5>41</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Oeil pathologie</s0>
<s5>45</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Eye disease</s0>
<s5>45</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Ojo patología</s0>
<s5>45</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Oculomotricité syndrome</s0>
<s5>46</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Oculomotor syndrome</s0>
<s5>46</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Oculomotricidad síndrome</s0>
<s5>46</s5>
</fC07>
<fC07 i1="09" i2="X" l="FRE"><s0>Mouvement involontaire</s0>
<s5>55</s5>
</fC07>
<fC07 i1="09" i2="X" l="ENG"><s0>Involuntary movement</s0>
<s5>55</s5>
</fC07>
<fC07 i1="09" i2="X" l="SPA"><s0>Movimiento involuntario</s0>
<s5>55</s5>
</fC07>
<fC07 i1="10" i2="X" l="FRE"><s0>Voie administration</s0>
<s5>69</s5>
</fC07>
<fC07 i1="10" i2="X" l="ENG"><s0>Route of administration</s0>
<s5>69</s5>
</fC07>
<fC07 i1="10" i2="X" l="SPA"><s0>Vía administración</s0>
<s5>69</s5>
</fC07>
<fN21><s1>020</s1>
</fN21>
<fN82><s1>PSI</s1>
</fN82>
</pA>
</standard>
<server><NO>PASCAL 03-0038727 INIST</NO>
<ET>Forty-one-year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: Cerebellar atrophy, multiphasic relapses, and response to IVIG</ET>
<AU>PRANZATELLI (Michael R.); TATE (Elizabeth D.); KINSHOURNE (Marcel); CAVINESS (Verne S. JR); MISHRA (Bibhuti)</AU>
<AF>The National Pediatric Myoclonus Center, Departments of Neurology and Pediatrics, Southern Illinois University School of Medicine/Springfield, Illinois/Etats-Unis (1 aut., 2 aut.); New School University and Tufts University/Winchester, Massachusetts/Etats-Unis (3 aut.); Massachusetts General Hospital/Boston, Massachusetts/Etats-Unis (4 aut.); Temple University/Philadelphia, Pennsylvania/Etats-Unis (5 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 2002; Vol. 17; No. 6; Pp. 1387-1390; Bibl. 20 ref.</SO>
<LA>Anglais</LA>
<EA>We report on an adult with opsoclonus-myoclonus-ataxia syndrome experiencing widely spaced neurological relapses, who was followed for 41 years. His responses to treatment are described.</EA>
<CC>002B17A01</CC>
<FD>Ataxie; Cervelet; Opsoclonie; Myoclonie; Immunoglobuline; Voie intraveineuse; Etude cas; Evolution; Récidive; Adulte; Chimiothérapie</FD>
<FG>Homme; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Cervelet pathologie; Trouble neurologique; Oeil pathologie; Oculomotricité syndrome; Mouvement involontaire; Voie administration</FG>
<ED>Ataxia; Cerebellum; Opsoclonus; Myoclonus; Immunoglobulins; Intravenous administration; Case study; Evolution; Relapse; Adult; Chemotherapy</ED>
<EG>Human; Nervous system diseases; Central nervous system disease; Cerebral disorder; Cerebellar disease; Neurological disorder; Eye disease; Oculomotor syndrome; Involuntary movement; Route of administration</EG>
<SD>Ataxia; Cerebelo; Opsoclonación; Mioclonia; Inmunoglobulina; Vía intravenosa; Estudio caso; Evolución; Recaida; Adulto; Quimioterapia</SD>
<LO>INIST-20953.354000105559450430</LO>
<ID>03-0038727</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002585 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 002585 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PascalFrancis |étape= Corpus |type= RBID |clé= Pascal:03-0038727 |texte= Forty-one-year follow-up of childhood-onset opsoclonus-myoclonus-ataxia: Cerebellar atrophy, multiphasic relapses, and response to IVIG }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |